Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study)
I Gentile, View ORCID ProfileA Giaccone, MM Scirocco, F Di Brizzi, F Cuccurullo, M Silvitelli, L Ametrano, FA Alfè, D Pietroluongo, I Irace, MR Chiariello, N De Felice, S Severino, View ORCID ProfileG Viceconte, View ORCID ProfileN Schiano Moriello, AE Maraolo, AR Buonomo, R Scotto, Federico II COVID team
doi: https://doi.org/10.1101/2024.06.07.24307681
I Gentile
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
A Giaccone
2AORN Ospedali dei Colli, Cotugno Hospital, Department of Infectious Diseases, Unit of Geriatric Infectious Diseases, Naples, Italy
MM Scirocco
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
F Di Brizzi
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
F Cuccurullo
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
M Silvitelli
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
L Ametrano
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
FA Alfè
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
D Pietroluongo
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
I Irace
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
MR Chiariello
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
N De Felice
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
S Severino
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
G Viceconte
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
N Schiano Moriello
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
AE Maraolo
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
AR Buonomo
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
R Scotto
1Department of Clinical Medicine and Surgery – Section of Infectious Diseases, University of Naples Federico II, Italy
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Supplementary Figure 2[supplements/307681_file02.jpg]
- Supplementary Figure 1[supplements/307681_file03.jpg]
- Supplementary Table 1[supplements/307681_file04.pdf]
Posted June 07, 2024.
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study)
I Gentile, A Giaccone, MM Scirocco, F Di Brizzi, F Cuccurullo, M Silvitelli, L Ametrano, FA Alfè, D Pietroluongo, I Irace, MR Chiariello, N De Felice, S Severino, G Viceconte, N Schiano Moriello, AE Maraolo, AR Buonomo, R Scotto, Federico II COVID team
medRxiv 2024.06.07.24307681; doi: https://doi.org/10.1101/2024.06.07.24307681
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study)
I Gentile, A Giaccone, MM Scirocco, F Di Brizzi, F Cuccurullo, M Silvitelli, L Ametrano, FA Alfè, D Pietroluongo, I Irace, MR Chiariello, N De Felice, S Severino, G Viceconte, N Schiano Moriello, AE Maraolo, AR Buonomo, R Scotto, Federico II COVID team
medRxiv 2024.06.07.24307681; doi: https://doi.org/10.1101/2024.06.07.24307681
Subject Area
Subject Areas
- Addiction Medicine (331)
- Allergy and Immunology (655)
- Anesthesia (175)
- Cardiovascular Medicine (2548)
- Dermatology (214)
- Emergency Medicine (387)
- Epidemiology (12034)
- Forensic Medicine (10)
- Gastroenterology (725)
- Genetic and Genomic Medicine (3950)
- Geriatric Medicine (372)
- Health Economics (661)
- Health Informatics (2553)
- Health Policy (984)
- Hematology (354)
- HIV/AIDS (817)
- Medical Education (391)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3713)
- Nursing (205)
- Nutrition (553)
- Oncology (1930)
- Ophthalmology (563)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (245)
- Palliative Medicine (71)
- Pathology (468)
- Pediatrics (1083)
- Primary Care Research (440)
- Public and Global Health (6382)
- Radiology and Imaging (1348)
- Respiratory Medicine (853)
- Rheumatology (389)
- Sports Medicine (336)
- Surgery (427)
- Toxicology (51)
- Transplantation (184)
- Urology (160)